CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

- Initiated Phase 3 registrational ECLIPSE program in chronic hepatitis delta with first patient enrolled in Q1 2025; Program received U.S. FDA Breakthrough and Fast Track designations and EMA PRIME ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

Add Yahoo as a preferred source to see more of our stories on Google. The National Thoroughbred Racing Association (NTRA), Daily Racing Form, and the National Turf Writers and Broadcasters (NTWAB) ...

Chad Metzler had a vision of what the Lake Norman Soccer Club's girls' program could be when he joined the organization as a coach four years ago. That dream quickly turned into reality, as the LNSC's ...

SARANAC LAKE — North Country Community College is inviting the public to join the college community for a program about the upcoming total solar eclipse. Seth McGowan, president of the Adirondack Sky ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...